Vilma Sniukiene

3.5k total citations · 1 hit paper
39 papers, 2.6k citations indexed

About

Vilma Sniukiene is a scholar working on Hepatology, Genetics and Epidemiology. According to data from OpenAlex, Vilma Sniukiene has authored 39 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hepatology, 10 papers in Genetics and 10 papers in Epidemiology. Recurrent topics in Vilma Sniukiene's work include Hepatitis C virus research (24 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Uterine Myomas and Treatments (10 papers). Vilma Sniukiene is often cited by papers focused on Hepatitis C virus research (24 papers), Chronic Lymphocytic Leukemia Research (10 papers) and Uterine Myomas and Treatments (10 papers). Vilma Sniukiene collaborates with scholars based in United States, Germany and France. Vilma Sniukiene's co-authors include Clifford A. Brass, Janice K. Albrecht, Navdeep Boparai, Ira M. Jacobson, Mark Sulkowski, Fred Poordad, Bruce R. Bacon, Jean–Pierre Bronowicki, K. Rajender Reddy and Savino Bruno and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Vilma Sniukiene

39 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

2011 1.9k citations Fred Poordad, Jonathan McCone et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Vilma Sniukiene

Since Specialization

Citations

This map shows the geographic impact of Vilma Sniukiene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vilma Sniukiene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vilma Sniukiene more than expected).

Fields of papers citing papers by Vilma Sniukiene

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vilma Sniukiene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vilma Sniukiene. The network helps show where Vilma Sniukiene may publish in the future.

Co-authorship network of co-authors of Vilma Sniukiene

This figure shows the co-authorship network connecting the top 25 collaborators of Vilma Sniukiene. A scholar is included among the top collaborators of Vilma Sniukiene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vilma Sniukiene. Vilma Sniukiene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health-Related Quality of Life With Ulipristal Acetate for Treatment of Uterine Leiomyomas 2019 ·Obstetrics and Gynecology ·Andrea S. Lukes, David E. Soper, Amanda Harrington, Vilma Sniukiene, Yifan Mo, Patrick Gillard, L.P. Shulman	18
2	Ulipristal Acetate for Treatment of Symptomatic Uterine Leiomyomas 2018 ·Obstetrics and Gynecology ·James A. Simon, William H. Catherino, James H. Segars, Rick E. Blakesley, (unknown), Vilma Sniukiene, Ayman Al‐Hendy	39
3	Ulipristal Acetate for Treatment of Uterine Leiomyomas 2018 ·Obstetrics and Gynecology ·James Liu, David E. Soper, Andrea S. Lukes, (unknown), Thomas Kimble, Robin Kroll, Madhuja Mallick, (unknown), Patrick Gillard, Amanda Harrington, Vilma Sniukiene, L.P. Shulman	30
4	A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom 2017 ·Menopause The Journal of The North American Menopause Society ·Robin Kroll, David F. Archer, Yu‐Hua Lin, Vilma Sniukiene, James Liu	29
5	A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom 2017 ·Journal of Women s Health ·David F. Archer, Thomas Kimble, (unknown), (unknown), Vilma Sniukiene, James Liu	35
6	Ulipristal Acetate Treatment of Uterine Fibroids in Black and Obese Women: Venus I Subgroup Analyses [28G] 2017 ·Obstetrics and Gynecology ·James A. Simon, William H. Catherino, Rick E. Blakesley, (unknown), Vilma Sniukiene, Ayman Al‐Hendy	4
7	Ulipristal acetate (UPA) treatment of symptomatic uterine fibroids (UF): VENUS II subgroup analyses by race and BMI 2017 ·Fertility and Sterility ·David E. Soper, Andrea S. Lukes, (unknown), Thomas Kimble, Robin Kroll, (unknown), (unknown), Vilma Sniukiene, L.P. Shulman, (unknown)	1
8	First US-based phase 3 study of ulipristal acetate (UPA) for symptomatic uterine fibroids (UF): results of VENUS-I 2016 ·Fertility and Sterility ·James A. Simon, William H. Catherino, James H. Segars, Rick E. Blakesley, (unknown), Vilma Sniukiene, Ayman Al‐Hendy	12
9	Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa‐2b/ribavirin 2013 ·Alimentary Pharmacology & Therapeutics ·Stuart C. Gordon, Eric M. Yoshida, Eric Lawitz, Bruce R. Bacon, Mark Sulkowski, Mitchell Davis, Fred Poordad, J.‐P. Bronowicki, Rafael Esteban, Vilma Sniukiene, Margaret Burroughs, Weiping Deng, Frank J. Dutko, Clifford A. Brass, Janice K. Albrecht, K. Rajender Reddy	17
10	Analysis of boceprevir resistance associated amino acid variants (RAVs) in two phase 3 boceprevir clinical studies 2013 ·Virology ·Richard J. O. Barnard, John A. Howe, Robert A. Ogert, Stefan Zeuzem, Fred Poordad, Stuart C. Gordon, Robert Ralston, Xiao Tong, Vilma Sniukiene, Julie Strizki, (unknown), Jianmin Long, Ping Qiu, Clifford A. Brass, Janice K. Albrecht, Margaret Burroughs, Scott Vuocolo, Daria J. Hazuda	54
11	Population pharmacokinetics of peginterferon alfa-2b in pediatric patients with chronic hepatitis C 2013 ·European Journal of Clinical Pharmacology ·Christine Xu, Samir K. Gupta, Gopal Krishna, David L. Cutler, Stefan Wirth, Cristina Galoppo, Mirta Ciocca, (unknown), Stephanie Noviello, Vilma Sniukiene	5
12	Factors That Predict Response of Patients With Hepatitis C Virus Infection to Boceprevir 2012 ·Gastroenterology ·Fred Poordad, Jean–Pierre Bronowicki, Stuart C. Gordon, Stefan Zeuzem, Ira M. Jacobson, Mark Sulkowski, Thierry Poynard, Timothy R. Morgan, Cliona Molony, Lisa D. Pedicone, Heather L. Sings, Margaret Burroughs, Vilma Sniukiene, Navdeep Boparai, Venkata Sasikiran Goteti, Clifford A. Brass, Janice K. Albrecht, Bruce R. Bacon	150
13	Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial 2012 ·Hepatology ·Mark S. Sulkowski, Fred Poordad, M.P. Manns, Jean–Pierre Bronowicki, K. Rajender Reddy, Stephen A. Harrison, Nezam H. Afdhal, Heather L. Sings, Lisa D. Pedicone, Kenneth Koury, Vilma Sniukiene, Margaret Burroughs, Janice K. Albrecht, Clifford A. Brass, Ira M. Jacobson	52
14	1194 SUSTAINED VIROLOGIC RESPONSE AND BOCEPREVIR RESISTANCE-ASSOCIATED VARIANTS OBSERVED IN PATIENTS INFECTED WITH HCV GENOTPYPE 1A/1B WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN 2011 ·Journal of Hepatology ·Clifford A. Brass, Richard J. O. Barnard, John A. Howe, Robert A. Ogert, Robert Ralston, Navdeep Boparai, Margaret Burroughs, Vilma Sniukiene, Patricia Méndez, J. Albrecht	9
15	Boceprevir for Untreated Chronic HCV Genotype 1 Infection breakdown → 2011 ·New England Journal of Medicine ·Fred Poordad, Jonathan McCone, Bruce R. Bacon, Savino Bruno, Michael P. Manns, Mark Sulkowski, Ira M. Jacobson, K. Rajender Reddy, Zachary Goodman, Navdeep Boparai, Mark J. DiNubile, Vilma Sniukiene, Clifford A. Brass, Janice K. Albrecht, Jean–Pierre Bronowicki	1888
16	Four-Week Therapy With Peginterferon Alfa-2B/Ribavirin Effectively Predicts Sustained Virologic Response in Treatment-NaïVE and Previous-Treatment-Failure Patients With HCV-1 Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin 2011 ·Gastroenterology ·John M. Vierling, Eric Lawitz, Fred Poordad, Mark Sulkowski, Marc Bourlière, Marı́a Buti, Curtis Cooper, Joseph Galati, Janice K. Albrecht, Navdeep Boparai, Clifford A. Brass, Margaret Burroughs, Vilma Sniukiene, Savino Bruno	1
17	452 EFFICACY AMONG NORTH AMERICAN AND EUROPEAN HCV GENOTYPE-1 TREATMENT-NAIVE AND PREVIOUS NON-RESPONDERS AND RELAPSERS TO PEGINTERFERON/RIBAVIRIN WHEN TREATED WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2B/RIBAVIRIN 2011 ·Journal of Hepatology ·Patrick Marcellin, John M. Vierling, Laurent Alric, Mario Pirisi, Albert Tran, Janice K. Albrecht, Clifford A. Brass, Navdeep Boparai, Vilma Sniukiene, Margaret Burroughs	2
18	Adherence to Assigned Dosing Regimen and Sustained Virologic Response Among Hepatitis C Genotype 1 Treatment-NaïVE and PEG/Ribavirin Treatment-Failures Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin 2011 ·Gastroenterology ·Stuart C. Gordon, Eric Lawitz, Bruce R. Bacon, Mark Sulkowski, Eric M. Yoshida, Mitchell Davis, Navdeep Boparai, Vilma Sniukiene, Margaret Burroughs, Clifford A. Brass, Janice K. Albrecht, K. Rajender Reddy	2
19	Response-Guided Therapy With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin Reduces Treatment Duration in NaïVE and Peginterferon Alfa-2B/Ribavirin Previous-Treatment-Failure Patients With HCV Genotype 1 2011 ·Gastroenterology ·Michael P. Manns, Fred Poordad, Bruce R. Bacon, Savino Bruno, Rafael Esteban, Marcelo Silva, Marı́a Buti, Margaret Burroughs, Vilma Sniukiene, Navdeep Boparai, Clifford A. Brass, Janice K. Albrecht, Jean–Pierre Bronowicki	3
20	Sustained Virologic Response and Boceprevir Resistance-Associated Variants Observed in Patients Infected With HCV Genotype 1A/1b When Treated With Boceprevir Plus Peginterferon Alfa-2B/Ribavirin 2011 ·Gastroenterology ·Clifford A. Brass, Richard J. O. Barnard, John A. Howe, Robert A. Ogert, Robert Ralston, Navdeep Boparai, Margaret Burroughs, Vilma Sniukiene, Patricia Méndez, Janice K. Albrecht	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact